As must as I see why you choose the comparison, one thing to note is that Medicine company was a very safe investment given they had data from Phase1-3 to back their claim up (Novartis massively overpaid as they always do
)......To get to the point alone is years away for Nyrada (I say given they haven't started Phase 1... atleast 5 years away)...Some them
being in clinical trials is not the same as Nyrada being in clinical trials .... They are years apart
Another big bet on Medicine company is their CV events data that will be read out in 2023....
I have seen this deal deal being thrown out to create a hype, but you need to just look at some facts ... Not to say Nyrada can't get a good deal.... But at the same time they have a high chance of failure as all biotechs do... Positive pre clinical data is not an indicator of risk free successful trials ....
(20min delay)